Valerio Berdini

Virtual Screening Using Protein-Ligand Docking: Avoiding Artificial Enrichment

Paul Watson, Marcel L. Verdonk, Christopher W. Murray, 2004, J. Chem. Inf. Model..

Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors.

Christopher W Murray, Paul N. Mortenson, Valerio Berdini, 2015, ACS medicinal chemistry letters.

Fragment-Based Screening by X-ray Crystallography

Miles Stuart Congreve, I. J. Tickle, Valerio Berdini, 2007 .

2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.

Giuseppe Nano, Luca Nicolini, Piercarlo Fantucci, 2005, Journal of medicinal chemistry.

Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design.

Paul G Wyatt, Valerio Berdini, V. Berdini, 2008, Journal of medicinal chemistry.

Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity.

Mladen Vinković, Paul G Wyatt, Jayne Curry, 2009, Journal of medicinal chemistry.

Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design.

Ian Collins, Michelle D Garrett, Valerio Berdini, 2007, Journal of medicinal chemistry.

Identification of inhibitors of protein kinase B using fragment-based lead discovery.

Marcel L Verdonk, Paul G Wyatt, Michelle D Garrett, 2007, Journal of medicinal chemistry.

Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.

Ian Collins, Paul Workman, Edward McDonald, 2006, Bioorganic & medicinal chemistry.